Literature DB >> 1895393

Alternative pathway for induction of human immunodeficiency virus gene expression: involvement of the general transcription machinery.

M Sakaguchi1, B Zenzie-Gregory, J E Groopman, S T Smale, S Y Kim.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) is viable and mitogen inducible in the absence of its binding sites for the inducible transcription factor NF-kappa B. We have investigated alternative mechanisms for induction of HIV-1 transcription. Using transient transfection assays, we found that transcription from an HIV-1 LTR containing mutant kappa B sites was activated 10- to 20-fold in a variety of human cell types by the phorbol ester phorbol myristate acetate (PMA). The promoter elements conferring this inducibility were localized to the region downstream of nucleotide -70, which contains the TATA and TAR elements and binding sites for transcription factors Sp1 and LBP-1. Synthetic promoters containing only Sp1 sites and a TATA element were also induced in transfection experiments as well as in in vitro transcription experiments with T-cell nuclear extracts. Moreover, promoters containing a TATA box in the absence of Sp1 sites or Sp1 sites in the absence of a TATA box were equally inducible in vitro, as was an RNA polymerase III promoter. The activities of RNA polymerases II and III and of the 38-kDa TATA-binding protein transcription factor IID (TFIID), were not induced by PMA, but electrophoretic mobility shift assays revealed a highly inducible protein-DNA complex that interacted specifically with the TATA sequence. This protein-DNA complex appeared to be much larger than that found with the 38-kDa human TFIID expressed in bacteria. Taken together, these data suggest that a component of the general transcription machinery, and possibly a TFIID-associated protein, is induced in T cells by PMA.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1895393      PMCID: PMC249034     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

Review 1.  Regulation of expression of human immunodeficiency virus.

Authors:  G N Pavlakis; B K Felber
Journal:  New Biol       Date:  1990-01

2.  The NF kappa B independent cis-acting sequences in HIV-1 LTR responsive to T-cell activation.

Authors:  Y C Lu; N Touzjian; M Stenzel; T Dorfman; J G Sodroski; W A Haseltine
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

3.  GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase.

Authors:  S P Jackson; J J MacDonald; S Lees-Miller; R Tjian
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

Review 4.  HIV trans-activation and transcription control mechanisms.

Authors:  K A Jones
Journal:  New Biol       Date:  1989-11

Review 5.  Transcription by RNA polymerase III.

Authors:  E P Geiduschek; G P Tocchini-Valentini
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

6.  Synergistic activation by the glutamine-rich domains of human transcription factor Sp1.

Authors:  A J Courey; D A Holtzman; S P Jackson; R Tjian
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

7.  An in vitro transcription analysis of early responses of the human immunodeficiency virus type 1 long terminal repeat to different transcriptional activators.

Authors:  Y C Li; J Ross; J A Scheppler; B R Franza
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

8.  Factors affecting cellular tropism of human immunodeficiency virus.

Authors:  S Kim; K Ikeuchi; J Groopman; D Baltimore
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

9.  A human cell factor is essential for HIV-1 Rev action.

Authors:  D Trono; D Baltimore
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

10.  TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes.

Authors:  D Harrich; J Garcia; R Mitsuyasu; R Gaynor
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

View more
  14 in total

1.  NF-kappa B homodimer binding within the HIV-1 initiator region and interactions with TFII-I.

Authors:  M A Montano; K Kripke; C D Norina; P Achacoso; L A Herzenberg; A L Roy; G P Nolan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

2.  Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity.

Authors:  M C Estable; B Bell; A Merzouki; J S Montaner; M V O'Shaughnessy; I J Sadowski
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

Review 3.  The Road Less Traveled: HIV's Use of Alternative Routes through Cellular Pathways.

Authors:  Ailie Marx; Akram Alian
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

4.  Non-Metabolic Role of PKM2 in Regulation of the HIV-1 LTR.

Authors:  Satarupa Sen; Satish L Deshmane; Rafal Kaminski; Shohreh Amini; Prasun K Datta
Journal:  J Cell Physiol       Date:  2016-06-10       Impact factor: 6.384

5.  C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes.

Authors:  A J Henderson; X Zou; K L Calame
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

6.  Differential requirements for HIV-1 replication in naive and memory CD4 T cells from asymptomatic HIV-1 seropositive carriers and AIDS patients.

Authors:  A Cayota; F Vuillier; D Scott-Algara; V Feuillie; G Dighiero
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

7.  Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.

Authors:  J W Maciaszek; D A Talmage; G A Viglianti
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages.

Authors:  A V Moses; C Ibanez; R Gaynor; P Ghazal; J A Nelson
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

9.  Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.

Authors:  Y Su; W Popik; P M Pitha
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

10.  Dynamic transcription factor activity profiling in 2D and 3D cell cultures.

Authors:  Abigail D Bellis; Beatriz Peñalver Bernabé; Michael S Weiss; Seungjin Shin; Stanley Weng; Linda J Broadbelt; Lonnie D Shea
Journal:  Biotechnol Bioeng       Date:  2012-09-18       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.